For help on how to get the results you want, see our search tips.
2 results
Medicine type
Exceptional circumstances Remove Exceptional circumstances filter
Biosimilar Remove Biosimilar filter
Orphan medicine Remove Orphan medicine filter
Medicine
Paediatric investigation plans Remove Paediatric investigation plans filter
Referrals Remove Referrals filter
Categories
Human Remove Human filter
-
List item
Referral: Factor VIII
associated names: Iblias, Elocta, Kovaltry, Nuwiq, Obizur, NovoEight, Voncento, ReFacto AF, Kogenate Bayer, Helixate NexGen, Advate, Article 31 referrals
Status: European Commission final decision, opinion/position date: 14/09/2017, EC decision date: 10/10/2017, Last updated: 05/12/2017 -
List item
Referral: Adakveo (new)
crizanlizumab, associated names: Adakveo, Article 20 procedures
Status: Procedure started, opinion/position date: 26/01/2023, Last updated: 27/01/2023